Drug Type Monoclonal antibody |
Synonyms TWP 101, TWP-101 |
Target |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Urothelial Carcinoma | Phase 1 | CN | 07 Feb 2021 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 30 Dec 2020 | |
Melanoma | Phase 1 | CN | 30 Dec 2020 | |
Solid tumor | Phase 1 | CN | - |
Phase 1 | 13 | hiubkdklbe(kdbngfnlbc) = kqegvawccb nluucymokz (aqrwpgawyj ) View more | Positive | 26 May 2023 |